DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Keywords: risk
| MO-C930-IePD-F4-3 | Hazard Testing to Probe Points of Weakness in Automated Planning Tools K Nealon1,2*, R Douglas2, E Han1,2, S Kry1,2, V Reed2, S Simiele1,2, L Zhang2, L Court1,2 (1) University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, (2) University of Texas MD Anderson Cancer Center, Houston, TX |
| MO-FG-201-1 | Experience and Survey Results From a National Hands-On Workshop On Simulated Error Training for the Physics Plan Review P Johnson1,2*, L Schubert3, G Kim4, J Faught5, C Buckey6, L Conroy7, S Luk8, D Schofield9, S Parker10, (1) University of Florida Health Proton Therapy Institute, Jacksonville, FL, (2) University of Florida, Gainesville, FL (3) University of Colorado Denver, Aurora, CO, (4) UC San Diego, La Jolla, CA, (5) Memphis, TN, (6) Mayo Clinic Arizona, Phoenix, AZ, (7) Princess Margaret Cancer Centre, Toronto, ON, (8) University of Vermont Medical Center, Burlington, VT, (9) AdventHealth Orlando, Clermont, FL, (10) Wake Forest Baptist Health High Point Medical Center, Winston-salem, NC |
| MO-J-BRA-0 | Managing Implanted Devices S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-1 | Dosimetric Concerns of Post-Mastectomy Tissue Expanders During External Beam Radiation Therapy S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-2 | Clinical Management of Cardiac Implantable Electronic Device (CIED) Patients S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-3 | Clinical Practices of Managing Implantable Medical Devices for Proton Therapy S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-4 | A Review of Managing Commonly Seen Implanted Devices for Radiotherapy Patients S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-5 | Q & A S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| PO-GePV-I-42 | Importance of Determining the Maximum Magnetic Displacement Forces for Implanted Devices Everywhere Within the Magnet Bore: A 3T-7T Comparison Study L Bardwell Speltz*, K Kirby, P Trester, I Langenfeld, M Bernstein, A Fagan, Mayo Clinic, Rochester, MN |
| PO-GePV-M-302 | Investigating Blockchain Technology for HealthCare CyberSecurity D Davis*, J Gerdes, University of South Carolina College of Engineering and Computing, Columbia, SC |
| PO-GePV-M-349 | Quantitative Evaluation of Radiodermatitis Following Whole-Breast Radiotherapy with Various Color Space Models: A Feasibility Study S Park1*, J Kim2, C Choi2, J Park2, J Kim2, (1) Veterans Health Service Medical Center, Seoul, KR, (2) Seoul National University Hospital, Seoul, KR |
| PO-GePV-T-94 | Investigation of KV Imaging Dose in Accelerated Partial Breast Irradiation (APBI) Y Song1*, X Zhai2, Y Liang3, B Mueller4, D Guttmann5, D Roth O'Brien6, L Braunstein7, (1) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(2) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(3) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(4) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(5) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(6) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(7) Memorial Sloan-Kettering Cancer Center, New York, NY |
| PO-GePV-T-135 | The TOPAS Extension for Secondary Cancer Risk Evaluation After Radiotherapy G Tamborino1, H Lee1*, A Bertolet1, J Schuemann1, C Lee2, H Paganetti1, (1) Massachusetts General Hospital, Boston, MA, (2) National Cancer Institute, Bethesda, MD |
| PO-GePV-T-207 | Radiation Dose Tolerance of a Medtronic Deep Brain Stimulator Based On OSLD Measurement M Klash1*, S Klash2, E Mcclelland3, L Brennan4, J Grubic5, (1) KSEC, Belmont, Ohio, (2) VAPHS, Pittsburgh, PA, (3) VAPHS, Pittsburgh, PA, (4) VAPHS, Pittsburgh, PA, (5) VAPHS, Pittsburgh, PA |
| PO-GePV-T-212 | Radiation Dose Tolerance Assessment of the Zio Heart Monitor S Klash1*, L Brennan2, J Graham3, (1) VAPHS, Pittsburgh, PA, (2) VAPHS, Pittsburgh, PA, (3) VAPHS, Pittsburgh, PA |
| PO-GePV-T-213 | Black Swans in Radiation Therapy K Maloney*, L Myers, Versant Medical Physics and Radiation Safety |
| SU-E-BRC-3 | FMEA of FLASH On a Clinical LINAC Shows Setup and Beam Gating as Largest Risks M Rahman1*, R Zhang1,2,3, D Gladstone1,2,3, B Williams1,2,3, E Chen4, L Thompson3, P Bruza1, B Pogue1,3,5,6, (1) Thayer School of Engineering, Dartmouth College, Hanover, NH, (2) Department of Medicine, Radiation Oncology, Geisel School of Medicine, Dartmouth College Hanover NH, (3) Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, (4) Cheshire Medical Center, Keene NH Department of Surgery, (5) Geisel School of Medicine, Dartmouth College, Hanover NH, (6) University of Wisconsin-Madison, Madison, WI |
| SU-F-BRA-8 | Using FMEA to Evaluate the Changes in Patient Risk for a New Automated Breast Planning Workflow K O'grady*, L KUO, G Tang, J Moran, L Hong, C Della Biancia, K Ohri, A Ng, E Lin, L Santanam, Memorial Sloan Kettering Cancer Center, New York, NY |
| TH-D-BRC-2 | Applications of a CT-Mesh Hybrid Computational Phantom for Patient-Specific Risk Prediction of Radiation-Induced Second Cancer in Proton Therapy E Kollitz1*, M Roew1, H Han2, M Pinto1, F Kamp3, C Kim2, M Schwarz4, C Belka5, W Newhauser6, G Dedes1, K Parodi1, (1) Ludwig Maximilian University of Munich, Garching B. Munich, DE, (2) Hanyang University, Seoul, KR, (3) University Hospital of Cologne, Cologne, DE, (4) University of Washington, Seattle, WA, (5) Hospital of the Ludwig Maximilian University of Munich, Munich, DE, (6) Louisiana State University, Baton Rouge, LA |
| TU-D1030-IePD-F2-3 | Segmentation of the Left Anterior Descending Coronary Artery Using Curvature-Guided Deep Learning for Lung Cancer Patients Treated with Radiotherapy Y Yue*, A Curtis, S Ng, K Huang, T Lautenschlaeger, Indiana University- School of Medicine, Indianapolis, IN |
| WE-FG-207-0 | Gonadal & Fetal Shielding Updates J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-1 | Regulatory Implications of Changes in Patient Shielding Practices J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-2 | Implementing Change in Patient Shielding Practices J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-3 | A Technologist's View of Patient Shielding J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-4 | Patient Shielding: What's Next? J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-5 | Q & A J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |